Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | growth hormone secretagogue receptor | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | rhodopsin-like orphan GPCR | growth hormone secretagogue receptor | 289 aa | 243 aa | 23.1 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Polyketide synthase Pks2 | 0.0032 | 0.4168 | 0.5576 |
Mycobacterium tuberculosis | Probable membrane bound polyketide synthase Pks6 | 0.005 | 0.7476 | 1 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsE | 0.0022 | 0.2228 | 0.2981 |
Mycobacterium ulcerans | multifunctional mycocerosic acid synthase membrane-associated Mas | 0.0036 | 0.4752 | 0.6357 |
Brugia malayi | AMP-binding enzyme family protein | 0.0031 | 0.3948 | 0.3948 |
Mycobacterium tuberculosis | Polyketide synthase Pks12 | 0.0036 | 0.4752 | 0.6357 |
Mycobacterium tuberculosis | Polyketide synthase Pks13 | 0.005 | 0.7476 | 1 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsA | 0.0033 | 0.4361 | 0.5834 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsC | 0.0036 | 0.4752 | 0.6357 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSD | 0.0033 | 0.4361 | 0.581 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsD | 0.0033 | 0.4361 | 0.5834 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks5 | 0.0032 | 0.4168 | 0.5576 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSC | 0.0036 | 0.4752 | 0.6337 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0033 | 0.4361 | 0.5834 |
Onchocerca volvulus | Fatty acid synthase homolog | 0.006 | 0.9416 | 1 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0033 | 0.4361 | 0.5834 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks15 | 0.0014 | 0.061 | 0.0817 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks8 | 0.0027 | 0.3214 | 0.4299 |
Mycobacterium tuberculosis | Polyketide synthetase MbtC (polyketide synthase) | 0.0011 | 0.0229 | 0.0306 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSE | 0.0022 | 0.2228 | 0.2941 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.1592 | 0.0823 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0033 | 0.4361 | 0.5834 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSB | 0.0027 | 0.3131 | 0.4155 |
Mycobacterium tuberculosis | Probable thioesterase TesA | 0.0028 | 0.3311 | 0.443 |
Mycobacterium ulcerans | polyketide synthase Pks9 | 0.0022 | 0.2228 | 0.2981 |
Mycobacterium leprae | Polyketide synthase Pks13 | 0.005 | 0.7476 | 1 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsB | 0.0027 | 0.3131 | 0.4188 |
Toxoplasma gondii | type I fatty acid synthase, putative | 0.0024 | 0.2547 | 0.3708 |
Mycobacterium ulcerans | thioesterase | 0.0028 | 0.3311 | 0.443 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks7 | 0.0036 | 0.4752 | 0.6357 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsA | 0.0027 | 0.3131 | 0.4188 |
Mycobacterium tuberculosis | Phenyloxazoline synthase MbtB (phenyloxazoline synthetase) | 0.0031 | 0.3948 | 0.528 |
Mycobacterium ulcerans | polyketide synthase | 0.0036 | 0.4752 | 0.6357 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSA | 0.0033 | 0.4361 | 0.581 |
Toxoplasma gondii | type I fatty acid synthase, putative | 0.0036 | 0.4752 | 1 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks9 | 0.0019 | 0.1644 | 0.2199 |
Toxoplasma gondii | beta-ketoacyl synthase, N-terminal domain-containing protein | 0.0022 | 0.2149 | 0.2574 |
Mycobacterium ulcerans | polyketide synthase Pks13 | 0.005 | 0.7476 | 1 |
Mycobacterium leprae | Probable multifunctional mycocerosic acid synthase membrane associated enzyme Mas | 0.0036 | 0.4752 | 0.6337 |
Loa Loa (eye worm) | AMP-binding enzyme family protein | 0.0031 | 0.3948 | 0.3889 |
Loa Loa (eye worm) | fatty acid synthase | 0.0033 | 0.4277 | 0.4318 |
Mycobacterium tuberculosis | Probable fatty acid synthase Fas (fatty acid synthetase) | 0.0011 | 0.0042 | 0.0056 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.8643 | 1 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsC | 0.0033 | 0.4361 | 0.5834 |
Mycobacterium leprae | Probable polyketide synthase Pks1 | 0.0036 | 0.4752 | 0.6337 |
Mycobacterium ulcerans | fatty acid synthase Fas | 0.0011 | 0.0042 | 0.0056 |
Onchocerca volvulus | 0.0058 | 0.9025 | 0.9285 | |
Mycobacterium ulcerans | thioesterase TesA | 0.0028 | 0.3311 | 0.443 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks1 | 0.0024 | 0.2588 | 0.3461 |
Mycobacterium tuberculosis | Probable multifunctional mycocerosic acid synthase membrane-associated Mas | 0.0036 | 0.4752 | 0.6357 |
Brugia malayi | Beta-ketoacyl synthase, N-terminal domain containing protein | 0.0033 | 0.4361 | 0.4361 |
Mycobacterium ulcerans | polyketide synthase | 0.0033 | 0.4361 | 0.5834 |
Mycobacterium leprae | PROBABLE THIOESTERASE TESA | 0.0028 | 0.3311 | 0.4398 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsD | 0.0033 | 0.4361 | 0.5834 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 15 uM | Inhibition of ghrelin binding to Growth hormone secretagogue receptor expressed in BHK cells | ChEMBL. | 14698149 |
IC50 (binding) | = 15 uM | Inhibition of ghrelin binding to Growth hormone secretagogue receptor expressed in BHK cells | ChEMBL. | 14698149 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.